Monitor Q2 2026 results for guidance update, as management expects to revise full-year outlook based on first and second quarter performance. The $2.50/share burden from exiting the Medicare Advantage Part D product remains a significant headwind.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 23 $172.71entry
- T+1 · 7mo ago +0.54%α −0.25% · $173.64
- T+5 · 7mo ago +13.77%α +12.29% · $196.49
- T+20 · 6mo ago +5.52%α +0.88% · $182.24
- T+60 · 4mo ago +30.49%α +25.57% · $225.37
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Molina Healthcare reported Q1 2026 GAAP EPS of $0.27 (miss vs $1.94 consensus) and reaffirmed full-year 2026 adjusted EPS guidance of at least $5.00, burdened by $2.50/share from exiting its Medicare Advantage Part D product. The stock is bearish due to the significant earnings miss and ongoing margin pressures.
Key Financial Metrics
Key Facts
- Q1 2026 GAAP EPS was $0.27 vs $1.94 consensus, a 86.1% miss
- Adjusted EPS was $2.35 vs $1.57 next-quarter consensus, still below expectations
- Company reaffirmed full-year 2026 adjusted EPS guidance of at least $5.00, burdened by $2.50/share from exiting Medicare Advantage Part D product
- Premium revenue of $10.17B was below $10.89B consensus
- Operating cash flow was $1.08B vs $190M same quarter last year
Financial Impact
GAAP EPS miss of $1.67 vs consensus, revenue miss of $718M
Risk Factors
- Ongoing medical cost pressure in Medicare and Marketplace segments
- Execution risk in exiting Medicare Advantage Part D product for 2027
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001179929-26-000020 |
| Document: moh-20260422.htm | 0001179929-26-000020 |
| Document: 0001179929-26-000020-index-headers.html | 0001179929-26-000020 |
| Document: 0001179929-26-000020-index.html | 0001179929-26-000020 |
| Document: 0001179929-26-000020.txt | 0001179929-26-000020 |
| 8-K Data (Synthetic) | 0001179929-26-000020 |
Track record
19 reports on MOH
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +20.13% at T+20 after the Jun 10, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry $232.95 Now $233.09 +0.06% settles Feb 16
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $211.22 Now $233.09 +10.35% settles Feb 12
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $212.00 Now $233.09 +9.95% settles Feb 12
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $209.49 Now $233.09 +11.27% settles Feb 11
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $209.25 Now $233.09 +11.39% settles Feb 9
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $206.35 Now $233.09 +12.96% settles Feb 8
- Nov 6, 202610d ago 8-K Neutral 2/10 Entry $203.35 Now $233.09 +14.63% settles Feb 5
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $204.78 Now $233.09 +13.82% settles Jan 28
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $198.10 Now $233.09 +17.66% settles Jan 26
- Oct 21, 202626d ago 8-K Mixed 6/10 Entry $216.64 Now $233.09 +7.59% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers